Our analysis results revealed notably higher levels of PLVAP expression among IDH wild forms, non-codeleted 1p19q subforms, and unmethylated MGMT promoter subforms in comparison to levels in gliomas of the IDH mutation subtype (Figure 1C and D for total WHO grades; E, F for low WHO grade; G, H for high WHO grades) and the co-deleted 1p19q subform (Figure 1I and J) in combination with methylated MGMT promoter subtype (Figure 1K and L) according to the TCGA and CGGA databases. Here, MGMT is linked to central nervous system cancer.